- Home
- ACHL vs GLST Comparison
ACHL vs GLST Comparison
Compare ACHL & GLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHL
- GLST
- Stock Information
- Founded
- ACHL 2016
- GLST 2019
- Country
- ACHL United Kingdom
- GLST United States
- Employees
- ACHL N/A
- GLST N/A
- Industry
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- GLST Consumer Electronics/Appliances
- Sector
- ACHL Health Care
- GLST Industrials
- Exchange
- ACHL Nasdaq
- GLST Nasdaq
- Market Cap
- ACHL 46.8M
- GLST 48.0M
- IPO Year
- ACHL 2021
- GLST 2022
- Fundamental
- Price
- ACHL $1.14
- GLST $11.41
- Analyst Decision
- ACHL Buy
- GLST
- Analyst Count
- ACHL 2
- GLST 0
- Target Price
- ACHL $4.00
- GLST N/A
- AVG Volume (30 Days)
- ACHL 266.7K
- GLST 435.0
- Earning Date
- ACHL 11-14-2024
- GLST 01-01-0001
- Dividend Yield
- ACHL N/A
- GLST N/A
- EPS Growth
- ACHL N/A
- GLST N/A
- EPS
- ACHL N/A
- GLST N/A
- Revenue
- ACHL N/A
- GLST N/A
- Revenue This Year
- ACHL N/A
- GLST N/A
- Revenue Next Year
- ACHL N/A
- GLST N/A
- P/E Ratio
- ACHL N/A
- GLST N/A
- Revenue Growth
- ACHL N/A
- GLST N/A
- 52 Week Low
- ACHL $0.63
- GLST $10.57
- 52 Week High
- ACHL $1.76
- GLST $12.67
- Technical
- Relative Strength Index (RSI)
- ACHL 55.79
- GLST 42.34
- Support Level
- ACHL $1.12
- GLST $11.37
- Resistance Level
- ACHL $1.18
- GLST $12.20
- Average True Range (ATR)
- ACHL 0.05
- GLST 0.10
- MACD
- ACHL -0.00
- GLST -0.06
- Stochastic Oscillator
- ACHL 33.33
- GLST 6.35
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
About GLST Global Star Acquisition Inc.
Global Star Acquisition Inc is a blank check company.